←
GI NURSES CONNECT powered by COR2ED1,002 posts
GI NURSES CONNECT powered by COR2ED avatar

GI NURSES CONNECT powered by COR2ED

@ginursesconnect

Independent Medical Education from COR2ED developed by GI NURSES CONNECT, experts in GI & LIVER (HCC) oncology nursing cor2ed.com/community-guideli…

◷ Joined March 2019▧ 436 Photos and videos
GI NURSES CONNECT powered by COR2ED avatar
GI NURSES CONNECT powered by COR2ED@ginursesconnect·Nov 17

📣 Catch up on data from #ESMO26! Drs @LizzySmyth1 & @YJanjigianMD share expert insights on new phase 3 gastric/GEJ cancer data from: 🔸 CLARITY-Gastric 01 (CG-01): a phase 3 study of sonesitatug vedotin in 2L+ advanced or metastatic Claudin 18.2-positive gastroesophageal carcinoma. Xu R-H, et al. Abstract LBA7, ESMO 2026 🔸 G-HOPE-001: First interim analysis of the phase 3 study of arcotatug tavatecan (IBI343/TAK-921) vs treatment of physician’s choice in previously treated advanced gastric/GEJ adenocarcinoma. Shitara K, et al. Abstract LBA77, ESMO 2026 📹 Watch their clinical takeaways in this post Watch the full update: cor2ed.com/n-connect/program… 🤝 Endorsed by @ESDO_tweets Supported by an Independent Educational Grant from AstraZeneca. In Spain, the information displayed is exclusively directed to Healthcare Professionals empowered to prescribe or dispense medicinal products. Please do not distribute in media, supporting materials or communication channels aimed at the general public. This content is intended for HCPs only. #MedEd #GIcancer #gastric #GEJ #OncTwitter #Medtwitter

0:47
COR2ED avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
COR2ED@COR2EDMedEd·Nov 2

📣Update from #ESMO26! Get expert insights on new data presented at the @myESMOAnnual Meeting In this video, Drs @LizzySmyth1 & @YJanjigianMDshare their views on Claudin 18.2-positive #Gastric & GEJ cancer data 📺 Visit our website for more ESMO updates: 🔸Assoc. Prof. Gerald Prager: #CRC & #PanCan 🔸Prof. Hong Jae Chon & Assoc. Prof. Lorenza Rimassa: #HCC 🔸Dr @tnewsomdavis: HER2-directed NSCLC 🔸Dr Louise Lim: #NSCLC 🔸Dr @jhaveri_komal: #BreastCancer 🔸Dr @DrIacovelli: #ProstateCancer & #BladderCancer Will new data impact clinical practice? 📺Watch the video updates to find out! cor2ed.com/n-connect/program… Gastric/GEJ cancer update supported by an Independent Educational Grant from AstraZeneca. In Spain, the information displayed is exclusively directed to Healthcare Professionals empowered to prescribe or dispense medicinal products. Please do not distribute in media, supporting materials or communication channels aimed at the general public. HCC and HER2-directed NSCLC updates are supported by Independent Educational Grants from BeOne and Bayer, respectively. All other updates supported by COR2ED. All content is intended for HCPs only. #MedEd #OncTwitter #pcsm #lcsm #MedTwitter

9:59
OncoAlert avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
OncoAlert@OncoAlert·Oct 29

Renowned oncologists joined @COR2EDMedEd live in Madrid🇪🇸 at #ESMO26 to share their expert insights on how new data could impact clinical practice. Watch their video updates on gastric/GEJ, colorectal, and pancreatic cancer, as well as HCC, non-small cell lung cancer (including HER2-directed NSCLC), breast, prostate, and bladder cancer. 👉 cor2ed.com/esmo-2026/ @LizzySmyth1, @YJanjigianMD, @tnewsomdavis, @LorenzaRimassa, @hongjaechon, @jhaveri_komal, @DrIacovelli

Post attachment
COR2ED avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
COR2ED@COR2EDMedEd·Oct 30

Are you signed up for the COR2ED LinkedIn newsletter yet? Subscribe now to receive this month's edition, out tomorrow! 🔦 We'll be shining a spotlight on #lungcancer, #breastcancer, and #narcolepsy, as well as sharing #ESMO26 highlights from renowned experts Subscribe here ⤵️ linkedin.com/build-relation/… >> This newsletter is for healthcare professionals only #MedEd #MedicalEducation #MedTwitter #OncTwitter #BCSM #LCSM #SleepMedicine

Post attachment
COR2ED avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
COR2ED@COR2EDMedEd·Oct 30

📣 Update from #ESMO26! Get expert insights on new data presented at the @myESMO Annual Meeting In this video, Prof. Hong Jae Chon & Assoc. Prof. Lorenza Rimassa share their views on new #HCC data 📺 Visit our website for more ESMO updates: 🔸Drs @LizzySmyth1 & @YJanjigianMD: #Gastric & GEJ cancer 🔸Assoc. Prof. Gerald Prager: #CRC & #PanCan 🔸Dr @tnewsomdavis: HER2-directed NSCLC 🔸Dr Louise Lim: #NSCLC 🔸Dr @jhaveri_komal: #BreastCancer 🔸Dr @DrIacovelli: #ProstateCancer & #BladderCancer Will new data impact clinical practice? 📺 Watch the video updates to find out! cor2ed.com/n-connect/program… Gastric/GEJ cancer update supported by an Independent Educational Grant from AstraZeneca. In Spain, the information displayed is exclusively directed to Healthcare Professionals empowered to prescribe or dispense medicinal products. Please do not distribute in media, supporting materials or communication channels aimed at the general public. HCC and HER2-directed NSCLC updates are supported by Independent Educational Grants from BeOne and Bayer, respectively. All other updates supported by COR2ED. All content is intended for HCPs only. #MedEd #OncTwitter #pcsm #lcsm #MedTwitter

5:53
HCC CONNECT powered by COR2ED avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
HCC CONNECT powered by COR2ED@hccconnectinfo·Oct 28

📣 Expert insights on HCC highlights from ESMO Prof. @hongjaechon & Assoc. Prof. Lorenza Rimassa joined us direct from the @myESMO Annual Meeting to review new HCC data from the BGB-B2033 & EMERALD-3 studies Watch their video update in this post 📺 🤝 This update is endorsed by @WarOnCancer & @GlobalLiver See more updates from ESMO in #GIcancer, #LungCancer, #BreastCancer & #GUcancer: cor2ed.com/n-connect/program… Supported by an Independent Educational Grant from BeOne. For HCPs only. #MedEd #HCC #OncTwitter #MedTwitter #ESMO26

5:53
GI NURSES CONNECT powered by COR2ED avatar
GI NURSES CONNECT powered by COR2ED@ginursesconnect·Oct 28

📣 GI update from #ESMO26! Assoc. Prof. Gerald Prager joined us at ESMO to share his views on #colorectalcancer & #pancreaticcancer highlights from the meeting Will emerging data from the #CheckMate 8HW & #RASolute 302 trials impact clinical practice? Watch the video to find out! 🤝 Programme endorsed by @WarOnCancer 📺 Get the abstract details & see more updates from @myESMO in #gastriccancer, #HCC, #breastcancer, #prostatecancer #bladder cancer & #NSCLC: cor2ed.com/n-connect/program… This educational programme is supported by COR2ED. For HCPs only. #MedEd #OncTwitter #MedTwitter #PanCan #CRCSM

3:54
GI NURSES CONNECT powered by COR2ED avatar
GI NURSES CONNECT powered by COR2ED@ginursesconnect·Oct 28

📢 Gastric/GEJ highlights from ESMO 2026 GI oncologists Drs @LizzySmyth1 & @YJanjigianMD joined us in Madrid to share their first thoughts on new data presented at the @myESMOmeeting Will phase 3 data from CLARITY-Gastric 01 (CG-01) & G-HOPE-001 change clinical practice? Watch to find out! 📺 See more from ESMO, incl. CRC, pancreatic & HCC updates: cor2ed.com/n-connect/program… Supported by an Independent Educational Grant from AstraZeneca. In Spain, the information displayed is exclusively directed to Healthcare Professionals empowered to prescribe or dispense medicinal products. Please do not distribute in media, supporting materials or communication channels aimed at the general public. This content is intended for HCPs only. #MedEd #GIcancer #gastric #GEJ #OncTwitter #Medtwitter #ESMO26 #crcsm #pancan #HCC

9:59
OncoAlert avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
OncoAlert@OncoAlert·Oct 26

Check out our Collaborators at COR2ED and this EXPERT insights from #ESMO26 GI oncologists Dr Lizzy Smyth, Dr Yelena Janjigian and Assoc. Prof. Gerald Prager join COR2ED at ESMO 2026 to provide their instant reactions on new data presented at the meeting. While Drs Smyth and Janjigian discuss gastric/GEJ cancer developments, Dr Prager will be focusing on colorectal and pancreatic cancer. @LizzySmyth1, @YJanjigianMD cor2ed.com/esmo-2026/gastric…

Post attachment
OncoAlert avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
OncoAlert@OncoAlert·Oct 25

🎙️ ESMO 2026: Expert insights in NSCLC Our Collaborators at @COR2EDMedEd met with medical oncologist Dr Louise Lim at ESMO 2026 , to discuss the latest non-small cell lung cancer (NSCLC) data and what it could mean for clinical practice. 👉 cor2ed.com/highlights-from-e… 🔬 Key studies in focus: ▪️ KRAS G12C: KRAScendo 1 (LBA5) ▪️ EGFR-mutated, MET-driven NSCLC: SAFFRON (LBA6) ▪️ First-line PD-L1-negative NSCLC: OptiTROP-Lung06 (LBA66) ▪️ EGFR-mutated NSCLC post-TKI: OptiTROP-Lung04 (LBA67) Join us for expert perspectives on these emerging data and their potential implications for treatment decisions.📍 Recorded at ESMO 2026 #ESMO26 #LungCancer

Post attachment
OncoAlert avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
OncoAlert@OncoAlert·Oct 24

🎥 #ESMO26 highlights from our collaborators @COR2EDMedEd Visit them at the main exhibition hall to learn more Watch Here👉 buff.ly/HBEGYqU Leading experts give quick takes on the key data, ~3 min per tumour type: 🔹 Gastric/GEJ: Smyth & Janjigian 🔹 CRC & pancreatic: Prager 🔹 HCC: Chon & Rimassa 🔹 NSCLC: Newsom-Davis & Lim 🔹 Breast: Jhaveri 🔹 GU: Iacovelli @YJanjigianMD, @tnewsomdavis, @LorenzaRimassa, @jhaveri_komal, @DrIacovelli @COR2EDMedEd

0:50
COR2ED avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
COR2ED@COR2EDMedEd·Oct 23

📢 #ESMO26 is here; keep a look out for our conference update! In this video, Dr @tnewsomdavis, who will be sharing an update on HER2-directed NSCLC, introduces the medical experts who will be joining us at ESMO ➡️Drs @LizzySmyth1 & @YJanjigianMD: #Gastric/GEJ cancer ➡️ Assoc. Prof. Gerald Prager: #CRC & #PanCan ➡️ Prof. Hong Jae Chon & Assoc. Prof. Lorenza Rimassa: #HCC / #LiverCancer ➡️ Dr Louise Lim: #NSCLC ➡️ Dr @jhaveri_komal: #BreastCancer ➡️ Dr @DrIacovelli: #ProstateCancer & #BladderCancer What will new data mean for clinical practice? 🎬 Keep checking back to see the videos as soon as they’re released to find out: cor2ed.com/n-connect/program… Gastric/GEJ cancer update supported by an Independent Educational Grant from AstraZeneca. In Spain, the information displayed is exclusively directed to Healthcare Professionals empowered to prescribe or dispense medicinal products. Please do not distribute in media, supporting materials or communication channels aimed at the general public. HCC and HER2-directed NSCLC updates are supported by Independent Educational Grants from BeOne and Bayer, respectively. All other updates supported by COR2ED All content is intended for HCPs only #MedEd #OncTwitter #MedTwitter #pcsm #lcsm

0:50
COR2ED avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
COR2ED@COR2EDMedEd·Jun 10

📣 Update from #ASCO26! Renowned experts share their views on new data emerging from the @ASCO Annual Meeting 👉 𝘏𝘌𝘙2-mutant NSCLC: Dr @herbloong & Dr @ipreeshagul data from SOHO-01, PRO data from Beamion LUNG-1, and more ~Endorsed by @WarOnCancer, @BiomarkerCo, @Exon20Group & @isliquidbiopsy (📺Video in this post! Slides also available: cor2ed.com/n-connect/program…) 👉 #NSCLC: Prof. @MarkSocinski reviews #LungCancer data from #LIBRETTO-432, WU-KONG28 & #HARMONi-6 ~Endorsed by International Cancer Advocacy Network, Biomarker Collaborative, Exon20 Group & International Society of Liquid Biopsy 👉 #ProstateCancer: Prof. Evan Yu reviews data from #PROTEUS & #TALAPRO-3 ~Endorsed by International Cancer Advocacy Network 👉 #ColorectalCancer, #PancreaticCancer & #LiverCancer: Prof. @HPrenen reviews data from #RASolute 302, #BREAKWATER & #EMERALD-3 ~Endorsed by International Cancer Advocacy Network & @dice_europe 👉 #BreastCancer: Dr @PtarantinoMD reviews data from #ASCENT-03, ASCENT-04, #TROPION-Breast02, #SERENA-6, #VIKTORIA-1, & #OPTIMA ~Endorsed by International Cancer Advocacy Network How will these data impact clinical practice? Watch the videos to find out! ▶️ cor2ed.com/n-connect/program… 𝘏𝘌𝘙2-mutant NSCLC update supported by an Independent Educational Grant from Bayer. All other updates supported by COR2ED. #MedEd #OncTwitter #MedTwitter #Oncology

4:40
OncoAlert avatar
⟳ GI NURSES CONNECT powered by COR2ED retweeted
OncoAlert@OncoAlert·Jun 5

Lung cancer 🫁 update from #ASCO26 👉 buff.ly/9P3rYdv Renowned lung cancer experts join our collaborators at COR2ED at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski. #LungCancer #NSCLC #SCLC @herbloong @ipreeshagul

Post attachment